$2.25 Billion is the total value of Novo Holdings A/S's 54 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 25.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VTI | VANGUARD INDEX FDStotal stk mkt | $430,912,000 | +7.8% | 1,933,900 | 0.0% | 19.12% | +15.8% | |
| BAM | Buy | BROOKFIELD ASSET MGMT INCcl a ltd vt sh | $156,768,000 | +14.7% | 3,075,079 | +0.1% | 6.95% | +23.2% |
| MORF | MORPHIC HLDG INC | $151,822,000 | -9.3% | 2,645,446 | 0.0% | 6.74% | -2.6% | |
| AAPL | APPLE INC | $142,083,000 | +12.1% | 1,037,404 | 0.0% | 6.30% | +20.4% | |
| INGN | Sell | INOGEN INC | $135,509,000 | -6.5% | 2,079,320 | -24.6% | 6.01% | +0.4% |
| EWTX | EDGEWISE THERAPEUTICS INC | $119,175,000 | -34.4% | 5,587,207 | 0.0% | 5.29% | -29.5% | |
| CYT | New | CYTEIR THERAPEUTICS INC | $103,585,000 | – | 4,840,413 | +100.0% | 4.60% | – |
| NKTX | NKARTA INC | $88,538,000 | -3.7% | 2,793,864 | 0.0% | 3.93% | +3.5% | |
| BOLT | BOLT BIOTHERAPEUTICS INC | $69,632,000 | -53.0% | 4,503,991 | 0.0% | 3.09% | -49.5% | |
| BABA | ALIBABA GROUP HLDG LTDsponsored ads | $57,312,000 | +17.7% | 214,827 | 0.0% | 2.54% | +26.4% | |
| ALGS | ALIGOS THERAPEUTICS INC | $53,311,000 | -10.3% | 2,614,563 | 0.0% | 2.36% | -3.7% | |
| SPRB | Sell | SPRUCE BIOSCIENCES INC | $50,606,000 | -38.9% | 4,514,336 | -9.5% | 2.24% | -34.4% |
| CABO | Sell | CABLE ONE INC | $49,538,000 | -42.8% | 25,898 | -45.3% | 2.20% | -38.5% |
| VERV | New | VERVE THERAPEUTICS INC | $47,794,000 | – | 793,265 | +100.0% | 2.12% | – |
| MIRM | MIRUM PHARMACEUTICALS INC | $42,277,000 | -12.8% | 2,445,147 | 0.0% | 1.88% | -6.3% | |
| VECT | New | VECTIVBIO HLDG AG | $41,067,000 | – | 3,522,019 | +100.0% | 1.82% | – |
| HRMY | Sell | HARMONY BIOSCIENCES HLDGS IN | $40,170,000 | -63.6% | 1,422,953 | -57.4% | 1.78% | -60.9% |
| LVTX | LAVA THERAPEUTICS NV | $36,201,000 | -28.4% | 3,327,312 | 0.0% | 1.61% | -23.0% | |
| RPHM | New | RENEO PHARMACEUTICALS INC | $32,005,000 | – | 3,430,377 | +100.0% | 1.42% | – |
| INZY | Sell | INOZYME PHARMA INC | $31,826,000 | -18.4% | 1,867,706 | -5.2% | 1.41% | -12.3% |
| PTGX | Sell | PROTAGONIST THERAPEUTICS INC | $26,928,000 | +19.8% | 600,010 | -30.9% | 1.19% | +28.7% |
| GRTX | GALERA THERAPEUTICS INC | $24,172,000 | +11.4% | 2,459,021 | 0.0% | 1.07% | +19.6% | |
| SPNE | Sell | SEASPINE HLDGS CORP | $22,845,000 | -0.6% | 1,113,846 | -15.7% | 1.01% | +6.7% |
| INSM | Buy | INSMED INC | $19,804,000 | +27.3% | 695,840 | +52.4% | 0.88% | +36.8% |
| FRLN | FREELINE THERAPEUTICS HLDGSsponsored ads | $19,244,000 | -33.7% | 2,361,229 | 0.0% | 0.85% | -28.8% | |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $19,260,000 | -0.7% | 1,997,880 | +1.8% | 0.85% | +6.6% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $17,568,000 | +20.2% | 675,160 | +46.2% | 0.78% | +29.0% |
| BPMC | BLUEPRINT MEDICINES CORP | $17,328,000 | -9.5% | 197,000 | 0.0% | 0.77% | -2.8% | |
| PRAX | Sell | PRAXIS PRECISION MEDICINES I | $16,643,000 | -79.2% | 910,450 | -62.7% | 0.74% | -77.7% |
| MIST | MILESTONE PHARMACEUTICALS IN | $13,918,000 | -5.0% | 2,530,585 | 0.0% | 0.62% | +2.0% | |
| CMPI | CHECKMATE PHARMACEUTICALS IN | $12,934,000 | -50.9% | 2,170,100 | 0.0% | 0.57% | -47.2% | |
| GLTO | GALECTO INC | $12,639,000 | -16.6% | 2,497,791 | 0.0% | 0.56% | -10.4% | |
| FLXN | FLEXION THERAPEUTICS INC | $11,550,000 | -8.0% | 1,403,370 | 0.0% | 0.51% | -1.3% | |
| LEGN | Buy | LEGEND BIOTECH CORPsponsored ads | $11,481,000 | +55.7% | 279,676 | +10.0% | 0.51% | +66.9% |
| TMCI | New | TREACE MED CONCEPTS INC | $10,097,000 | – | 323,000 | +100.0% | 0.45% | – |
| EAR | Sell | EARGO INC | $9,462,000 | -74.3% | 237,071 | -67.8% | 0.42% | -72.4% |
| ABCL | New | ABCELLERA BIOLOGICS INC | $9,292,000 | – | 422,382 | +100.0% | 0.41% | – |
| INSP | Buy | INSPIRE MED SYS INC | $8,919,000 | +7.7% | 46,151 | +15.4% | 0.40% | +15.8% |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $8,889,000 | -36.9% | 555,186 | -29.6% | 0.39% | -32.3% |
| XENT | INTERSECT ENT INC | $8,697,000 | -18.2% | 508,922 | 0.0% | 0.39% | -12.1% | |
| LUNG | PULMONX CORP | $8,253,000 | -3.5% | 187,047 | 0.0% | 0.37% | +3.7% | |
| ZGNX | Buy | ZOGENIX INC | $7,647,000 | -3.7% | 442,550 | +8.8% | 0.34% | +3.4% |
| SILK | SILK RD MED INC | $7,062,000 | -5.5% | 147,557 | 0.0% | 0.31% | +1.3% | |
| KNTE | KINNATE BIOPHARMA INC | $6,984,000 | -25.3% | 300,000 | 0.0% | 0.31% | -19.7% | |
| NARI | INARI MED INC | $6,736,000 | -12.8% | 72,212 | 0.0% | 0.30% | -6.3% | |
| SPRO | SPERO THERAPEUTICS INC | $6,546,000 | -5.2% | 468,902 | 0.0% | 0.29% | +1.8% | |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $5,879,000 | – | 34,679 | +100.0% | 0.26% | – |
| AKUS | AKOUOS INC | $5,764,000 | -9.5% | 459,290 | 0.0% | 0.26% | -2.7% | |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $5,174,000 | -41.0% | 53,300 | -58.5% | 0.23% | -36.5% |
| VRNA | Sell | VERONA PHARMA PLCsponsored ads | $4,978,000 | -29.0% | 761,205 | -9.2% | 0.22% | -23.5% |
| AFIB | ACUTUS MED INC | $4,330,000 | +27.0% | 255,000 | 0.0% | 0.19% | +36.2% | |
| PHVS | Buy | PHARVARIS N V | $2,071,000 | +48.0% | 111,144 | +122.3% | 0.09% | +58.6% |
| BAMR | New | BROOKFIELD ASSET MGMT REINScl a exch lt vtg | $1,102,000 | – | 21,179 | +100.0% | 0.05% | – |
| FSTX | Sell | F-STAR THERAPEUTICS INC | $23,000 | -93.9% | 2,703 | -92.2% | 0.00% | -93.8% |
| GRAY | Exit | GRAYBUG VISION INC | $0 | – | -209,748 | -100.0% | -0.05% | – |
| GRTS | Exit | GRITSTONE ONCOLOGY INC | $0 | – | -278,478 | -100.0% | -0.11% | – |
| CRNX | Exit | CRINETICS PHARMACEUTICALS IN | $0 | – | -271,378 | -100.0% | -0.17% | – |
| PCVX | Exit | VAXCYTE INC | $0 | – | -416,937 | -100.0% | -0.34% | – |
| CNST | Exit | CONSTELLATION PHARMCETICLS I | $0 | – | -699,415 | -100.0% | -0.68% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD INDEX FDS | 41 | Q3 2022 | 64.7% |
| INOGEN INC | 34 | Q2 2022 | 68.8% |
| VANGUARD INTL EQUITY INDEX F | 29 | Q4 2016 | 37.6% |
| AMICUS THERAPEUTICS INC | 22 | Q3 2023 | 4.1% |
| AKEBIA THERAPEUTICS INC | 21 | Q3 2020 | 4.8% |
| VERONA PHARMA PLC | 21 | Q2 2022 | 1.9% |
| CORVUS PHARMACEUTICALS INC | 20 | Q4 2020 | 7.1% |
| INSPIRE MED SYS INC | 20 | Q3 2023 | 1.8% |
| CABLE ONE INC | 19 | Q3 2023 | 9.7% |
| FLEXION THERAPEUTICS INC | 19 | Q3 2021 | 4.7% |
View Novo Holdings A/S's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyteir Therapeutics, Inc. | August 03, 2023 | 1,547,136 | 4.4% |
| Disc Medicine, Inc. | June 28, 2023 | 1,090,772 | 4.8% |
| Galera Therapeutics, Inc. | June 28, 2023 | 2,100,000 | 4.9% |
| VectivBio Holding AGSold out | May 26, 2023 | 0 | 0.0% |
| LanzaTech Global, Inc. | February 17, 2023 | 15,814,845 | 8.1% |
| Bolt Biotherapeutics, Inc.Sold out | January 04, 2023 | 0 | 0.0% |
| Arcellx, Inc. | December 12, 2022 | 1,750,000 | 4.0% |
| MINERVA SURGICAL INC | November 03, 2022 | 1,322,473 | 4.5% |
| Milestone Pharmaceuticals Inc. | October 24, 2022 | 1,378,538 | 4.6% |
| Galecto, Inc. | September 30, 2022 | 2,497,791 | 9.8% |
View Novo Holdings A/S's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-03-28 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-20 |
| SC 13D/A | 2024-03-20 |
| 144 | 2024-03-18 |
| 4 | 2024-03-18 |
| SC 13D/A | 2024-03-18 |
| 144 | 2024-03-14 |
| SC 13D/A | 2024-03-07 |
View Novo Holdings A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.